TYB
mRNA Vaccine For Birth Defects Didn't Work WellWon't Be Continued: Moderna
by Tyler Durden
Monday, Oct 27, 2025 - 02:45 AM
Moderna - which has been around less than 10 years and 'somehow' convinced the government to mandate their mRNA jabs for hundreds of millions of Americans to participate in normal life during the pandemic - announced this week that its vaccine for birth defects did not perform well in a clinical trial, so they're scrapping it.
The company's mRNA vaccine for cytomegalovirus (CMV) did not meet the primary efficacy endpoint in preventing CMV infection in healthy females of childbearing age (16-40) in a phase 3 randomized trial involving around 7,500 women.
Pregnant mothers can pass CMV to their babies - with about 1 in every 200 born with CMV and around 20% of babies who contract it suffering from birth defects or long term health problems, including hearing loss.
As the Epoch Times notes further, Moderna’s CMV vaccine utilizes messenger ribonucleic acid (mRNA) technology, just like its only approved shots, which target COVID-19.
Moderna executives said in January that the trial for the CMV vaccine, mRNA-1647, needed to keep going because interim results did not show enough efficacy, but expressed optimism that the shot would ultimately be successful, noting it could be the first such vaccine on the market because no others exist as of yet.
https://www.zerohedge.com/medical/mrna-vaccine-birth-defects-didnt-work-well-wont-be-continued-moderna